<DOC>
	<DOC>NCT00208858</DOC>
	<brief_summary>The purpose of this study is to gather pilot data to determine feasibility of and guide the development of a larger clinical trial investigating the effects of topiramate as an adjunct to nicotine replacement therapy and behavioral counseling in smoking cessation treatment. It is hypothesized that topiramate will decrease nicotine craving and result in improved outcomes for smoking cessation.</brief_summary>
	<brief_title>A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Male, between ages of 1855 Meets DSMIV criteria for nicotine dependence Smoke at least 20 cigarettes per day Motivated to quit smoking Serious or unstable medical conditions Current psychiatric disorder requiring medication or treatment Taking medication that create risk of interaction with study drug Current participation in another smoking cessation treatment</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>